Paige is the builder of computational pathology products created to help patients and doctors perform more informed medical diagnostics. This company was founded by Thomas Fuchs, David Klimstra, Norman Selby and Peter Schüffler in 2017 and is headquartered in New York, NY. Paige.ai also helps life sciences companies evaluate and design personalized treatments for patients thanks to their use of machine learning and technology.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 3/2/2023 | Series C-1 | $656.14MM | $XXX.XX | $XXX.XX |
| 3/10/2021 | Series C | $605.33MM | $XXX.XX | $XXX.XX |
| 7/13/2020 | Series B | $226.79MM | $XXX.XX | $XXX.XX |
| 4/23/2020 | Series A-1 | $52.33MM | $XXX.XX | $XXX.XX |
| 2/5/2018 | Series A | $46.18MM | $XXX.XX | $XXX.XX |
